AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

Glycopyrrolate

6 registrations across 3 African markets— 6 active

Markets with Glycopyrrolate

🇿🇦South Africa
4 registrations
4 active
🇷🇼Rwanda
1 registration
1 active
🇹🇿Tanzania
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
PYROLATE INJECTION
Solution for Injection
🇷🇼RwandaBROOKES PHARMA (PRIVATE) LIMITEDactiveMay 2030
PLACOGY 1 mg/5 ml VIAL🇿🇦South AfricaHetero Drugs South Africa (Pty) LtdactiveFeb 2030
PLACOGY 4 mg/20 ml VIAL🇿🇦South AfricaHetero Drugs South Africa (Pty) LtdactiveFeb 2030
GLYOPY 1 mg/5 ml VIAL🇿🇦South AfricaHetero Drugs South Africa (Pty) LtdactiveFeb 2030
GLYOPY 4 mg/20 ml VIAL🇿🇦South AfricaHetero Drugs South Africa (Pty) LtdactiveFeb 2030
Pyrolate
Solution for injection
🇹🇿TanzaniaBROOKES PHARMA PVT LIMITEDactive—

Glycopyrrolate in Africa — Regulatory Overview

Glycopyrrolate is registered across 3 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Rwanda, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.

Of the 6 registrations, 6 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.